BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 28610674)

  • 1. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
    Ishikawa G; Acquah SO; Salvatore M; Padilla ML
    Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
    Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
    PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
    Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
    Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.
    Moua T; Westerly BD; Dulohery MM; Daniels CE; Ryu JH; Lim KG
    Chest; 2016 May; 149(5):1205-14. PubMed ID: 26836940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases.
    Ba C; Wang H; Jiang C; Shi X; Jin J; Fang Q
    BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute exacerbations of fibrotic interstitial lung disease.
    Churg A; Wright JL; Tazelaar HD
    Histopathology; 2011 Mar; 58(4):525-30. PubMed ID: 20854464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
    Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
    Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.
    Suzuki A; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Hasegawa Y
    Clin Respir J; 2018 Mar; 12(3):895-903. PubMed ID: 28026113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.
    Ueno F; Kitaguchi Y; Shiina T; Asaka S; Yasuo M; Wada Y; Kinjo T; Yoshizawa A; Hanaoka M
    Respiration; 2020; 99(1):9-18. PubMed ID: 31554007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features, anti-cancer treatments and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema.
    Minegishi Y; Kokuho N; Miura Y; Matsumoto M; Miyanaga A; Noro R; Saito Y; Seike M; Kubota K; Azuma A; Kida K; Gemma A
    Lung Cancer; 2014 Aug; 85(2):258-63. PubMed ID: 24894326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer.
    Enomoto Y; Inui N; Kato T; Baba T; Karayama M; Nakamura Y; Ogura T; Suda T
    Lung Cancer; 2016 Jun; 96():63-7. PubMed ID: 27133752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
    Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting survival across chronic interstitial lung disease: the ILD-GAP model.
    Ryerson CJ; Vittinghoff E; Ley B; Lee JS; Mooney JJ; Jones KD; Elicker BM; Wolters PJ; Koth LL; King TE; Collard HR
    Chest; 2014 Apr; 145(4):723-728. PubMed ID: 24114524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.